Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Effect of direct-to-consumer genomewide profiling to assess disease risk.

Bloss CS, Schork NJ, Topol EJ.

N Engl J Med. 2011 Feb 10;364(6):524-34. doi: 10.1056/NEJMoa1011893. Epub 2011 Jan 12.

2.

Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group.

Genet Med. 2010 Dec;12(12):839-43. doi: 10.1097/GIM.0b013e3181f872c0.

PMID:
21042222
3.

The path to personalized medicine.

Hamburg MA, Collins FS.

N Engl J Med. 2010 Jul 22;363(4):301-4. doi: 10.1056/NEJMp1006304. Epub 2010 Jun 15. No abstract available. Erratum in: N Engl J Med. 2010 Sep 9;363(11):1092.

4.

Whole-genome sequencing breaks the cost barrier.

Bonetta L.

Cell. 2010 Jun 11;141(6):917-9. doi: 10.1016/j.cell.2010.05.034.

5.

Direct-to-consumer personal genome testing: ethical and regulatory issues that arise from wanting to 'know' your DNA.

Samuel GN, Jordens CF, Kerridge I.

Intern Med J. 2010 Mar;40(3):220-4. doi: 10.1111/j.1445-5994.2010.02190.x. Review.

PMID:
20446967
6.

Challenges in the clinical application of whole-genome sequencing.

Ormond KE, Wheeler MT, Hudgins L, Klein TE, Butte AJ, Altman RB, Ashley EA, Greely HT.

Lancet. 2010 May 15;375(9727):1749-51. doi: 10.1016/S0140-6736(10)60599-5. Epub 2010 Apr 29. No abstract available.

PMID:
20434765
7.

Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence.

Eng C, Sharp RR.

Sci Transl Med. 2010 Feb 3;2(17):17cm5. doi: 10.1126/scitranslmed.3000214.

PMID:
20371476
8.

Individual genomes on the horizon.

Lifton RP.

N Engl J Med. 2010 Apr 1;362(13):1235-6. doi: 10.1056/NEJMe1001090. Epub 2010 Mar 10. No abstract available.

PMID:
20220178
9.

Social networkers' attitudes toward direct-to-consumer personal genome testing.

McGuire AL, Diaz CM, Wang T, Hilsenbeck SG.

Am J Bioeth. 2009;9(6-7):3-10. doi: 10.1080/15265160902928209. Erratum in: Am J Bioeth. 2009 Aug;9(8):77.

10.

Genome-wide association studies and human disease: from trickle to flood.

Visscher PM, Montgomery GW.

JAMA. 2009 Nov 11;302(18):2028-9. doi: 10.1001/jama.2009.1643. No abstract available.

PMID:
19903925
11.

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.

Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J; Centers for Disease Control and Prevention.

Genet Med. 2009 Aug;11(8):559-67. doi: 10.1097/GIM.0b013e3181b13a6c.

12.

Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.

Paynter NP, Chasman DI, Buring JE, Shiffman D, Cook NR, Ridker PM.

Ann Intern Med. 2009 Jan 20;150(2):65-72.

13.

An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons.

McGuire AL, Burke W.

JAMA. 2008 Dec 10;300(22):2669-71. doi: 10.1001/jama.2008.803. No abstract available.

14.

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG.

J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.

15.

Risks and benefits of direct-to-consumer genetic testing remain unclear.

Kuehn BM.

JAMA. 2008 Oct 1;300(13):1503-5. doi: 10.1001/jama.300.13.1503. No abstract available.

PMID:
18827199
16.

Knowing me, knowing you.

Lenzer J, Brownlee S.

BMJ. 2008 Apr 19;336(7649):858-60. doi: 10.1136/bmj.39534.451458.AD. Review. No abstract available.

17.

Out of sequence: how consumer genomics could displace clinical genetics.

Foster MW, Sharp RR.

Nat Rev Genet. 2008 Jun;9(6):419. doi: 10.1038/nrg2374. No abstract available.

PMID:
18414402
18.

Genomic profiles for disease risk: predictive or premature?

Offit K.

JAMA. 2008 Mar 19;299(11):1353-5. doi: 10.1001/jama.299.11.1353. No abstract available.

PMID:
18349097
19.

A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions.

Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ.

Am J Hum Genet. 2008 Mar;82(3):593-9. doi: 10.1016/j.ajhg.2007.12.020.

20.

Letting the genome out of the bottle--will we get our wish?

Hunter DJ, Khoury MJ, Drazen JM.

N Engl J Med. 2008 Jan 10;358(2):105-7. doi: 10.1056/NEJMp0708162. No abstract available.

Supplemental Content

Support Center